Terra Stockholders Show Overwhelming Support for CF Industries' Proposal to Acquire Terra

Among the shares expected to see active trade in Monday's session are the oil companies as well as Cadbury, iBasis, LDK Solar, J.M. Smucker, Tech Data, Terra, Tyson Foods, and TowerJazz.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5132078 for the full story.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5132046 for the full story.

The market was yet again flat today, closing a bit on the downside.  Gold, however, jumped in the morning a attained a new record high!  This weekend, in my Market Forecast & Sector Watch, I said, "GLD is now in uncharted territory, with little resistance.  If the momentum is strong, GLD could run up fast and [...]

The market started out a bit weak, but, managed to came back up to close in the green.  Coal stocks were strong today:  MEE +5.68%, CNX +1.88%, BTU +2.37%, ACI +2.14%.  I mentioned unusual options activities in MEE in last night’s article.  Today I bought some Jan 40 calls on MEE and took a quick [...]

Gilead Sciences, Inc (GILD) is awaiting the outcome of the Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration (FDA) scheduled on December 10, 2009. The committee will review Gilead ’s aztreonam for inhalation solution, an investigational product for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients [...]

(GILD) Gilead Sciences Awaits Committee Outcome

Gilead Sciences, Inc (GILD) is awaiting the outcome of the Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration (FDA) scheduled on December 10, 2009. The committee will review Gilead ’s aztreonam for inhalation solution, an investigational product for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF). Earlier, in September 2008, the drug was denied approval by the FDA, which then asked Gilead to resubmit the application with more data. 

In September 2009, the drug received conditional marketing approval in Canada and Europe under the trade name Cayston (aztreonam lysine 75 mg powder and solvent for nebuliser solution). Gilead plans to make the product available in Germany and the UK in early 2010. Aztreonam formulated with lysine is a proprietary formulation of aztreonam developed specifically for inhalation, which has orphan drug status in the US and Europe . Applications for marketing approval of Cayston are pending in Australia , Switzerland and Turkey .
 
CF is a chronic, debilitating genetic disease that affects the respiratory and digestive systems of approximately 70,000 people worldwide, including 35,000 people in the European Union. Cayston was granted conditional marketing authorization to address the unmet medical need of the CF patients. A decision regarding full marketing authorization will be based on the completion of the ongoing phase III study examining the efficacy and safety of Cayston compared to Novartis’ (NVS) tobramycin inhalation solution (TOBI) in CF patients with pulmonary P. aeruginosa. 

During the third quarter conference call, Gilead stated that it expects to complete enrollment by the year end and make the data available towards the middle of next year. We believe positive data from this study will help it to receive approval from the regulatory authorities in both US and Europe . We have a Neutral recommendation on the stock.
Read the full analyst report on "GILD"
Read the full analyst report on "NVS"
Zacks Investment Research

Companies featured in this segment: Tesco plc (OTC:TSCDY), Wal-Mart Stores Incorporated (NYSE:WMT), Greggs (LSE:GRG), Diageo plc (NYSE:DEO), Kraft Foods Incorporated (NYSE:KFT), Cadbury plc (NYSE:CBY), CF Industries Holdings Incorporated (NYSE:CF), Braskem SA (NYSE:BAK), Sigdo Koppers SA (SCL:SK), Agrium (TSX:AGU)

Companies featured in this segment: Royal Dutch Shell plc (NYSE:RDS.A), Valero Engineering Corporation (NYSE:VLO), Lazard Limited (NYSE:LAZ), The Boeing Company (NYSE:BA), ABB Limited (NYSE:ABB), Brookfield Asset Management Incorporated (NYSE:BAM), Jacobs Engineering Group Incorporated (NYSE:JEC), CF Industries Holdings Incorporated (NYSE:CF), Fluor Corporation (NYSE:FLR), Exxon Mobil Corporation (NYSE:XOM), Oil & Natural Gas Limited (BSE:500312), Itochu Corporation (TYO:8001), Japan Petroleum Exploration Company Limited (TYO:1662), Marubeni Corporation (TYO:8002), Yara International ASA (OTC:YARIY)

Companies featured in this segment: Agrium Incorporated (NYSE:AGU), Terra Industries Incorporated (NYSE:TRA), CF Industries (NYSE:CF), ArcelorMittal (NYSE:MT), Duke Energy (NYSE:DUK), Denbury Resources Incorporated (NYSE:DNR), Scottish and Southern Energy plc (OTC:SSEZY), Electricite de France (EPA:EDF), Areva SA (EPA:CEI), Adhunik Group (BSE:532727), Tata Sponge Iron Limited (BSE:513010), Monnet Ispat & Energy Limited (BSE:513446), NMDC Limited (BSE:526371), Steel Authority of India Limited (BSE:500113), NTPC Limited (BSE:532555)

Companies featured in this segment: General Electric Company (NYSE:GE), BP plc (NYSE:BP), Dominion Resources Incorporated (NYSE:D), DuPont (NYSE:DD), Williams Companies Incorporated (NYSE:WMB), AES Corporation (NYSE:AES), CF Industries Holdings Incorporated (NYSE:CF), Terra Industries Incorporated (NYSE:TRA), Agrium Incorporated (NYSE:AGU), E.ON AG (OTC:EONGY), RWE AG (OTC:RWEOY), Energie Baden-Wuerttemburg AG (ETR:EBK), CEZ AS (PRG:BAACEZ), Edison SpA (BIT:EDN), and Scottish and Southern Energy plc (LSE:SSE)

Companies featured in this segment: Dow Chemical Company (NYSE:DOW), Westlake Chemical Corporation (NYSE:WLK), CF Industries Holdings Incorporated (NYSE:CF), USEC Incorporated (NYSE:USU), SPX Corporation (NYSE:SPW), Layne Christensen Company (NASDAQ:LAYN), StatoilHydro ASA (NYSE:STO), Total SA (NYSE:TOT), Korea Electric Power Corporation (NYSE:KEP), Baxter International Incorporated (NYSE:BAX), Alstom SA (EPA:ALO), Areva SA (EPA:CPI), Electricite de France (EPA:EDF), RWE Power (OTC:RWEOY), E.ON AG (OTC:EONGY), HTC Purenergy Incorporated (CVE:HTC), and Doosan Heavy Industries & Construction Company (SEO:034020)